These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32796472)

  • 1. The diagnostic performance of 99mTc-methionine single-photon emission tomography in grading glioma preoperatively: a comparison with histopathology and Ki-67 indices.
    Rani N; Singh B; Kumar N; Singh P; Hazari PP; Jaswal A; Gupta SK; Chhabra R; Radotra BD; Mishra AK
    Nucl Med Commun; 2020 Sep; 41(9):848-857. PubMed ID: 32796472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Rani N; Singh B; Kumar N; Singh P; Hazari PP; Vyas S; Hooda M; Chitkara A; Shekhawat AS; Gupta SK; Radotra BD; Mishra AK
    Cancer Biother Radiopharm; 2021 Sep; 36(7):568-578. PubMed ID: 32644819
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiation of Recurrent/Residual Glioma From Radiation Necrosis Using Semi Quantitative 99mTc MDM (Bis-Methionine-DTPA) Brain SPECT/CT and Dynamic Susceptibility Contrast-Enhanced MR Perfusion: A Comparative Study.
    Rani N; Singh B; Kumar N; Singh P; Hazari PP; Singh H; Kumar G; Radotra B; Kumar M; Bhattacharya A; Sharma R; Kohli A; Chhabra R; Gupta SK; Mishra AK
    Clin Nucl Med; 2018 Mar; 43(3):e74-e81. PubMed ID: 29356734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
    Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
    Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic algorithm for glioma grading using dynamic susceptibility contrast‑enhanced magnetic resonance perfusion and proton magnetic resonance spectroscopy.
    Nguyen DH; Nguyen DH; Le TD; Nguyen HK; Nguyen-Thi VA; Nguyen MD
    Biomed Rep; 2024 Mar; 20(3):56. PubMed ID: 38357240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.
    Usinskiene J; Ulyte A; Bjørnerud A; Venius J; Katsaros VK; Rynkeviciene R; Letautiene S; Norkus D; Suziedelis K; Rocka S; Usinskas A; Aleknavicius E
    Neuroradiology; 2016 Apr; 58(4):339-50. PubMed ID: 26767528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
    Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
    Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.
    Wu R; Watanabe Y; Arisawa A; Takahashi H; Tanaka H; Fujimoto Y; Watabe T; Isohashi K; Hatazawa J; Tomiyama N
    Jpn J Radiol; 2017 Oct; 35(10):613-621. PubMed ID: 28879406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas.
    Yao R; Cheng A; Liu M; Zhang Z; Jin B; Yu H
    J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):269-276. PubMed ID: 33346568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of multiple parameters obtained on 3T pulsed arterial spin-labeling, diffusion tensor imaging, and MRS and the Ki-67 labeling index in evaluating glioma grading.
    Fudaba H; Shimomura T; Abe T; Matsuta H; Momii Y; Sugita K; Ooba H; Kamida T; Hikawa T; Fujiki M
    AJNR Am J Neuroradiol; 2014; 35(11):2091-8. PubMed ID: 24994829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
    Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
    J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
    Guillevin R; Menuel C; Taillibert S; Capelle L; Costalat R; Abud L; Habas C; De Marco G; Hoang-Xuan K; Chiras J; Vallée JN
    Br J Cancer; 2011 Jun; 104(12):1854-61. PubMed ID: 21610707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
    Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
    Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
    Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of intraoperative ultrasound characteristics with pathological grades and Ki-67 proliferation index in intracranial gliomas.
    Baskan O; Silav G; Sari R; Canoz O; Elmaci I
    J Med Ultrason (2001); 2015 Apr; 42(2):231-7. PubMed ID: 26576577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.